ACHN - Achillion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
-70,870
-70,272
-85,236
-61,706
-5,030
Depreciation & amortization
1,183
1,158
1,126
955
694
Deferred income taxes
-
-
-
-
-
Stock based compensation
6,649
9,380
10,573
11,006
10,072
Change in working capital
8,640
-1,627
14,074
-16,336
323
Accounts receivable
-
-
-
-
-
Inventory
-
-
-
-
-
Accounts Payable
3,202
-2,940
-1,577
2,693
-2,285
Other working capital
-56,759
-62,527
-60,104
-68,161
4,873
Other non-cash items
-
-
-1,094
-565
-2,486
Net cash provided by operating activites
-56,505
-62,012
-59,478
-65,653
5,577
Cash flows from investing activities
Investments in property, plant and equipment
-254
-515
-626
-2,508
-704
Acquisitions, net
-
-
-
-
-
Purchases of investments
-210,082
-223,060
-345,490
-499,115
-692,525
Sales/Maturities of investments
266,207
289,891
372,091
562,292
394,575
Other investing activites
-
-
-
0
0
Net cash used for investing activites
55,873
66,316
25,975
60,669
-298,654
Cash flows from financing activities
Debt repayment
-206
-170
-351
-246
-249
Common stock issued
-
-
0
0
297,138
Common stock repurchased
-
-
-
-
-
Dividends Paid
-
-
-
-
-
Other financing activites
-
-
-175
0
0
Net cash used privided by (used for) financing activities
387
2,029
-262
520
301,138
Net change in cash
-245
6,333
-33,765
-4,464
8,061
Cash at beginning of period
35,273
43,648
77,261
81,725
73,664
Cash at end of period
35,028
49,981
43,496
77,261
81,725
Free Cash Flow
Operating Cash Flow
-56,505
-62,012
-59,478
-65,653
5,577
Capital Expenditure
-254
-515
-626
-2,508
-704
Free Cash Flow
-56,759
-62,527
-60,104
-68,161
4,873